The impact of Lactococcus lactis (probiotic nasal rinse) co‐culture on growth of patient‐derived strains of Pseudomonas aeruginosa

Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis

(2019) Do-Yeon Cho et al.   International Forum of Allergy & Rhinology

In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms

(2019) Do-Yeon Cho et al.   International Forum of Allergy & Rhinology

Mucins as multifunctional building blocks of biomaterials

(2018) Georgia Petrou et al.   Biomaterials Science

The Pseudomonas aeruginosa Complement of Lactate Dehydrogenases Enables Use of D- and L-Lactate and Metabolic Cross-Feeding

(2018) Yu-Cheng Lin et al.   mBio

Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa

(2018) Do-Yeon Cho et al.   American Journal of Rhinology & Allergy

Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis

(2017) Rodrigo D. De Oliveira Carvalho et al.   Frontiers in Microbiology

Topical Probiotics as a Therapeutic Alternative for Chronic Rhinosinusitis: A Preclinical Proof of Concept

(2016) Joseph S. Schwartz et al.   American Journal of Rhinology & Allergy

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis

(2016) Richard R. Orlandi et al.   International Forum of Allergy & Rhinology

Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease

(2016) Jeffrey M. Flynn et al.   PLoS Pathogens

Risk and Safety of Probiotics

(2015) Shira Doron et al.   CLINICAL INFECTIOUS DISEASES

A lactose fermentation product produced by Lactococcus lactis subsp. lactis, acetate, inhibits the motility of flagellated pathogenic bacteria

(2015) Shuichi Nakamura et al.   MICROBIOLOGY-SGM

Screening of Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary infections

(2014) Youenn Alexandre et al.   BMC MICROBIOLOGY

Management of the upper airway in cystic fibrosis

(2014) Elisa A. Illing et al.   CURRENT OPINION IN PULMONARY MEDICINE

Effect of Probiotics on Blood Pressure

(2014) Saman Khalesi et al.   HYPERTENSION

The role of the microbiome in exacerbations of chronic lung diseases

(2014) Robert P Dickson et al.   LANCET

EDGE-pro: Estimated Degree of Gene Expression in Prokaryotic Genomes

(2013) Tanja Magoc et al.   Evolutionary Bioinformatics

Effectiveness of Probiotics in the Prophylaxis of Necrotizing Enterocolitis in Preterm Neonates: A Systematic Review and Meta-analysis

(2013) Wanderley Marques Bernardo et al.   Jornal de Pediatria

The Microbiome of the Middle Meatus in Healthy Adults

(2013) Vijay R. Ramakrishnan et al.   PLoS One

Novel approaches to the treatment ofPseudomonas aeruginosainfections in cystic fibrosis

(2012) Matthew N. Hurley et al.   EUROPEAN RESPIRATORY JOURNAL

Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients

(2012) C. V. Robinson et al.   JOURNAL OF MEDICAL MICROBIOLOGY

The Evolution of Mutualism in Gut Microbiota Via Host Epithelial Selection

(2012) Jonas Schluter et al.   PLOS BIOLOGY

The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

(2012) Justyna Bien et al.   Therapeutic Advances in Gastroenterology

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

(2010) Cole Trapnell et al.   NATURE BIOTECHNOLOGY

Staphylococcus aureus Virulence Expression Is Impaired by Lactococcus lactis in Mixed Cultures

(2009) S. Even et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Proteolytic degradation of human salivary MUC5B by dental biofilms

(2009) C. Wickstrom et al.   MICROBIOLOGY-SGM